Skip to main content
OpenTrials

Clinical trial condition

Neurocognitive Disorders

Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.

7,736 public trials 1,424 recruiting studies
Refine in advanced search Browse all conditions

Neurocognitive Disorders trial results

Completed

Valproate in Dementia (VALID)

NCT00071721

Conditions
Aberrant Motor Behavior in Dementia, Alzheimer Disease, Behavior, +18 more
Locations
  • Sun Health Research Institute Sun City, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California, Irvine Irvine, California, United States
  • University of California, ADRC, San Diego La Jolla, California, United States
View all 46 locations
View Trial Details
Completed

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

NCT00440050

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Sun Health Research Institute/Arizona Consortium Sun City, Arizona, United States
  • University of California Irvine Irvine, California, United States
View all 51 locations
View Trial Details
Completed

A Study of Semagacestat for Alzheimer's Patients

NCT01035138

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sun City, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Costa Mesa, California, United States
View all 71 locations
View Trial Details
Completed

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

NCT01078636

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Banner Sun Health Research Institute Sun City, Arizona, United States
  • University of California, Irvine Irvine, California, United States
View all 55 locations
View Trial Details
Completed

ADNI: Alzheimer's Disease Neuroimaging Initiative

NCT00106899

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +9 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center Phoenix, Arizona, United States
  • Sun Health / Arizona Consortium Sun City, Arizona, United States
  • University of California, Irvine Irvine, California, United States
View all 59 locations
View Trial Details

Related conditions